Early resuscitation of dengue shock syndrome in children with hyperosmolar sodium-lactate: a randomized single-blind clinical trial of efficacy and safety

Dadang H Somasetia, Tatty E Setiati, Azhali M Sjahrodji, Ponpon S Idjradinata, Djatnika Setiabudi, Hubert Roth, Carole Ichai, Eric Fontaine, Xavier M Leverve, Dadang H Somasetia, Tatty E Setiati, Azhali M Sjahrodji, Ponpon S Idjradinata, Djatnika Setiabudi, Hubert Roth, Carole Ichai, Eric Fontaine, Xavier M Leverve

Abstract

Introduction: Dengue shock syndrome (DSS) fluid resuscitation by following the World Health Organization (WHO) guideline usually required large volumes of Ringer lactate (RL) that might induce secondary fluid overload. Our objective was to compare the effectiveness of the recommended volume of RL versus a smaller volume of a hypertonic sodium lactate solution (HSL) in children with DSS. The primary end point was to evaluate the effect of HSL on endothelial cell inflammation, assessed by soluble vascular cell adhesion molecule-1 (sVCAM-1) measurements. Secondarily, we considered the effectiveness of HSL in restoring hemodynamic fluid balance, acid-base status, and sodium and chloride balances, as well as in-hospital survival.

Methods: A prospective randomized single-blind clinical trial including 50 DSS children was conducted in the Pediatrics Department of Hasan Sadikin Hospital, Bandung, Indonesia. Only pediatric patients (2 to 14 years old) fulfilling the WHO criteria for DSS and new to resuscitation treatments were eligible. Patients were resuscitated with either HSL (5 ml/kg/BW in 15 minutes followed by 1 ml/kg/BW/h for 12 hours), or RL (20 ml/kg/BW in 15 minutes followed by decreasing doses of 10, 7, 5, and 3 ml/kg BW/h for 12 hours).

Results: In total, 50 patients were randomized and included in outcome and adverse-event analysis; 46 patients (8.2 ± 0.5 years; 24.9 ± 1.9 kg; mean ± SEM) completed the protocol and were fully analyzed (24 and 22 subjects in the HSL and RL groups, respectively). Baseline (prebolus) data were similar in both groups. Hemodynamic recovery, plasma expansion, clinical outcome, and survival rate were not significantly different in the two groups, whereas fluid accumulation was one third lower in the HSL than in the RL group. Moreover, HSL was responsible for a partial recovery from endothelial dysfunction, as indicated by the significant decrease in sVCAM-1.

Conclusion: Similar hemodynamic shock recovery and plasma expansion were achieved in both groups despite much lower fluid intake and fluid accumulation in the HSL group.

Trial registration: ClinicalTrials.gov NCT00966628. Registered 26 August 2009.

Figures

Figure 1
Figure 1
Profile of the randomized controlled trial.
Figure 2
Figure 2
Study flow chart.
Figure 3
Figure 3
Effect of treatments on systolic blood pressure and hematocrit. Open circles, RL; solid circles, HSL.
Figure 4
Figure 4
Effect of treatments on fluid balance. Open circles, RL; solid circles, HSL.
Figure 5
Figure 5
Effect of treatments on homeostasis (D-dimer) and endothelial cell dysfunction (sVCAM-1). Open bars, RL; solid bars, HSL. Comparisons were performed by using Wilcoxon tests for paired data (effect of time) and Mann–Whitney tests for unpaired data (difference between the two groups).
Figure 6
Figure 6
Effect of treatments on sodium and chloride balance. Open bars, RL; solid bars, HSL. Comparisons were performed by using Mann–Whitney tests.

References

    1. Halstead SB. Dengue. Lancet. 2007;370:1644–1652. doi: 10.1016/S0140-6736(07)61687-0.
    1. The World Health Organization and the Special Programme for Research and Training in Tropical Diseases, editor. Dengue guidelines for diagnosis, treatment and control. Geneva: WHO Library Cataloguing-in-Publication Data; 2009.
    1. Basu A, Chaturvedi UC. Vascular endothelium: the battlefield of dengue viruses. FEMS Immunol Med Microbiol. 2008;53:287–299. doi: 10.1111/j.1574-695X.2008.00420.x.
    1. Guzman MG, Kouri G. Dengue: an update. Lancet Infect Dis. 2002;2:33–42. doi: 10.1016/S1473-3099(01)00171-2.
    1. Rajapakse S. Dengue shock. J Emerg Trauma Shock. 2011;4:120–127. doi: 10.4103/0974-2700.76835.
    1. Bethell DB, Gamble J, Pham PL, Nguyen MD, Tran TH, Ha TH, Tran TN, Dong TH, Gartside IB, White NJ, Day NP. Noninvasive measurement of microvascular leakage in patients with dengue hemorrhagic fever. Clin Infect Dis. 2001;32:243–253. doi: 10.1086/318453.
    1. Koraka P, Murgue B, Deparis X, Van Gorp EC, Setiati TE, Osterhaus AD, Groen J. Elevation of soluble VCAM-1 plasma levels in children with acute dengue virus infection of varying severity. J Med Virol. 2004;72:445–450. doi: 10.1002/jmv.20007.
    1. Murgue B, Cassar O, Deparis X. Plasma concentrations of sVCAM-1 and severity of dengue infections. J Med Virol. 2001;65:97–104. doi: 10.1002/jmv.2007.
    1. Dung NM, Day NP, Tam DT, Loan HT, Chau HT, Minh LN, Diet TV, Bethell DB, Kneen R, Hien TT, White NJ, Farrar JJ. Fluid replacement in dengue shock syndrome: a randomized, double-blind comparison of four intravenous-fluid regimens. Clin Infect Dis. 1999;29:787–794. doi: 10.1086/520435.
    1. Ngo NT, Cao XT, Kneen R, Wills B, Nguyen VM, Nguyen TQ, Chu VT, Nguyen TT, Simpson JA, Solomon T, White NJ, Farrar J. Acute management of dengue shock syndrome: a randomized double-blind comparison of 4 intravenous fluid regimens in the first hour. Clin Infect Dis. 2001;32:204–213. doi: 10.1086/318479.
    1. Wills BA, Nguyen MD, Ha TL, Dong TH, Tran TN, Le TT, Tran VD, Nguyen TH, Nguyen VC, Stepniewska K, White NJ, Farrar JJ. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. N Engl J Med. 2005;353:877–889. doi: 10.1056/NEJMoa044057.
    1. Leverve XM, Boon C, Hakim T, Anwar M, Siregar E, Mustafa I. Half-molar sodium-lactate solution has a beneficial effect in patients after coronary artery bypass grafting. Intensive Care Med. 2008;34:1796–1803. doi: 10.1007/s00134-008-1165-x.
    1. Mustafa I, Roth H, Hanafiah A, Hakim T, Anwar M, Siregar E, Leverve XM. Effect of cardiopulmonary bypass on lactate metabolism. Intensive Care Med. 2003;29:1279–1285. doi: 10.1007/s00134-003-1860-6.
    1. Leverve XM, Mustafa I. Lactate: a key metabolite in the intercellular metabolic interplay. Crit Care. 2002;6:284–285. doi: 10.1186/cc1509.
    1. Ichai C, Armando G, Orban JC, Berthier F, Rami L, Samat-Long C, Grimaud D, Leverve X. Sodium lactate versus mannitol in the treatment of intracranial hypertensive episodes in severe traumatic brain-injured patients. Intensive Care Med. 2009;35:471–479. doi: 10.1007/s00134-008-1283-5.
    1. Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39:175–191. doi: 10.3758/BF03193146.
    1. Rahal L, Garrido AG, Cruz RJ, Jr, Silva E, Poli-de-Figueiredo LF. Fluid replacement with hypertonic or isotonic solutions guided by mixed venous oxygen saturation in experimental hypodynamic sepsis. J Trauma. 2009;67:1205–1212. doi: 10.1097/TA.0b013e31818b2567.
    1. Shih CC, Chen SJ, Chen A, Wu JY, Liaw WJ, Wu CC. Therapeutic effects of hypertonic saline on peritonitis-induced septic shock with multiple organ dysfunction syndrome in rats. Crit Care Med. 2008;36:1864–1872. doi: 10.1097/CCM.0b013e318173f982.
    1. van Haren FM, Sleigh J, Boerma EC, La Pine M, Bahr M, Pickkers P, van der Hoeven JG. Hypertonic fluid administration in patients with septic shock: a prospective randomized controlled pilot study. Shock. 2012;37:268–275. doi: 10.1097/SHK.0b013e31823f152f.
    1. Halestrap AP, Price NT. The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. Biochem J. 1999;343:281–299. doi: 10.1042/0264-6021:3430281.
    1. Chen H, Sun D. The role of Na-K-Cl co-transporter in cerebral ischemia. Neurol Res. 2005;27:280–286. doi: 10.1179/016164105X25243.
    1. Jayakumar AR, Norenberg MD. The Na-K-Cl co-transporter in astrocyte swelling. Metab Brain Dis. 2010;25:31–38. doi: 10.1007/s11011-010-9180-3.
    1. Jayakumar AR, Panickar KS, Curtis KM, Tong XY, Moriyama M, Norenberg MD. Na-K-Cl cotransporter-1 in the mechanism of cell swelling in cultured astrocytes after fluid percussion injury. J Neurochem. 2011;117:437–448. doi: 10.1111/j.1471-4159.2011.07211.x.
    1. Ichai C, Payen JF, Orban JC, Quintard H, Roth H, Legrand R, Francony G, Leverve XM. Half-molar sodium lactate infusion to prevent intracranial hypertensive episodes in severe traumatic brain injured patients: a randomized controlled trial. Intensive Care Med. 2013;39:1413–1422. doi: 10.1007/s00134-013-2978-9.
    1. Chiolero R, Tappy L, Gillet M, Revelly JP, Roth H, Cayeux C, Schneiter P, Leverve X. Effect of major hepatectomy on glucose and lactate metabolism. Ann Surg. 1999;229:505–513. doi: 10.1097/00000658-199904000-00009.
    1. Revelly JP, Tappy L, Martinez A, Bollmann M, Cayeux MC, Berger MM, Chiolero RL. Lactate and glucose metabolism in severe sepsis and cardiogenic shock. Crit Care Med. 2005;33:2235–2240. doi: 10.1097/01.CCM.0000181525.99295.8F.

Source: PubMed

3
Abonnere